Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O. V. Robustova"'
Publikováno v:
Oftalʹmologiâ, Vol 10, Iss 4, Pp 11-15 (2014)
In the literature review presents an analysis of epidemiological researches carried out in Russia and CIS on the study of the prevalence of different types of glaucoma, depending on race and ethnicity.
Externí odkaz:
https://doaj.org/article/49f631d8dc9f448b96cb09a508af413a
Publikováno v:
Oftalʹmologiâ, Vol 10, Iss 3, Pp 5-8 (2014)
В обзоре литературы представлен анализ зарубежных эпидемиологических исследований, касающихся изучения распространенности различных
Externí odkaz:
https://doaj.org/article/6cd4a8bf282842728a10aa942b0bc423
Publikováno v:
Vestnik oftalmologii. 136(5)
To study the hypotensive effectiveness and safety of Bimoptic Plus (bimatoprost 0.03% + timolol 0.5%) in patients with developed primary open-angle glaucoma (POAG).The study included 30 patients aged 57 to 72 years (45 eyes). The 1The study was compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6218b49ae86cdcf2af3521695a69b39d
https://pubmed.ncbi.nlm.nih.gov/33056969
https://pubmed.ncbi.nlm.nih.gov/33056969
Autor:
Elena N. Iomdina, Andrey A. Zamyatnin, Senin, Maxim V. Skulachev, O. A. Averina, V. P. Reddy, I. P. Khoroshilova-Maslova, Gjumrakch Aliev, O. V. Robustova, N. A. Kovaleva, Vladimir P. Skulachev
Publikováno v:
Frontiers in Bioscience. 20:892-901
Glaucoma is the main cause of irreversible blindness worldwide. This disease is characterized by apoptosis of retinal ganglion cells (RGC) and visual field loss that seems to be related to elevated intraocular pressure (IOP). Several lines of evidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6934c34366567c1eb5481caaf03d52b2
https://doi.org/10.2741/4343
https://doi.org/10.2741/4343
Publikováno v:
Vestnik oftalmologii. 126(1)
This study proposes new, original methods for diagnosis of glaucoma optic neuropathy--oscillatory potentials (OP) in an electroretinogram (ERG) to a long-term stimulus and in the 30 Hz flicker ERG (with identification of OP at frequencies of 80 to 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e77369a6a3e2ac387199c7aac5aa794a
https://pubmed.ncbi.nlm.nih.gov/20645569
https://pubmed.ncbi.nlm.nih.gov/20645569
Autor:
Maxim V. Skulachev, V. B. Saprunova, L. F. Sotnikova, N. A. Kovaleva, O. V. Robustova, Ivan I. Senin, Pavel P. Philippov, D. I. Pilipenko, I. V. Tsapenko, E. P. Kopenkin, Yu. P. Novikova, V. V. Neroev, E N Grigorian, A. I. Shchipanova, I. P. Khoroshilova-Maslova, E.N. Iomdina, Zh. N. Ivashchenko, L. A. Katargina, A. Yu. Grishanova, O. V. Kilina, Vladimir P. Skulachev, M. M. Archipova, Sergey S Korshunov, N.K. Tikhomirova, A. Zh. Fursova, N. G. Kolosova, Roman A. Zinovkin, Natalia A. Stefanova, Lora E. Bakeeva
Publikováno v:
Biochemistry. Biokhimiia. 73(12)
Mitochondria-targeted cationic plastoquinone derivative SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) has been investigated as a potential tool for treating a number of ROS-related ocular diseases. In OXYS rats suffering from a ROS-induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eb6f1c7e85cbba5ed8461f08edbaed
https://pubmed.ncbi.nlm.nih.gov/19120017
https://pubmed.ncbi.nlm.nih.gov/19120017